Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GOVX is expected to report earnings to rise 5.15% to -101 cents per share on November 12
Q3'26
Est.
$-1.02
Q2'26
Beat
by $1.30
Q1'26
Missed
by $2.08
Q4'25
Missed
by $2.27
Q3'25
Missed
by $0.02
The last earnings report on July 27 showed earnings per share of -97 cents, beating the estimate of -226 cents. With 68.70K shares outstanding, the current market capitalization sits at 1.93M.